EP-1846: Pseudo-CT generation from T1 and T2-weighted brain MRI based on a localised correlation approach  by Speier, C. et al.
S868                                                                                                                                                  ESTRO 35 2016 
_____________________________________________________________________________________________________ 
therapy planning (RTP) has not yet been established. We 
hypothesize that 7T MRI allows for improved GTV delineation 
over 1.5T or 3T MRI and have designed a clinical study to 
investigate this. However, increases in power deposition, 
susceptibility artefacts and geometrical distortions could 
significantly compromise the quality and interpretability of 
7T MR images. In this study we aim for qualitative and 
quantitative assessment of these effects when incorporating 
7T MR images into the neurosurgical navigation and RTP 
software. 
 
Material and Methods: MR images were acquired with a 
Siemens Magnetom 7T whole-body scanner and a Nova 
Medical 32-channel head coil. 7T MRI pulse sequences were 
selected to visualize both intracranial anatomy and tumour 
(MP2RAGE) and perilesional edema (T2-SPACE, SPACE FLAIR). 
Moreover, multi-echo gradient recalled echo (GRE) T2*-
weighted images were selected to visualize 
microvascularisation. A pilot study with 3 healthy volunteers 
was performed to optimize the anatomical image contrast by 
tuning the pulse sequences and scan protocols. Subject 
tolerability and side effects were assessed after each scan. A 
new anthropomorphic 3D phantom (CIRS Model 603A) was 
used to assess the geometrical image accuracy. A study-
specific workflow for the transfer and processing of the 7T 
MR images from the scan facility to the RTP and neurosurgical 
navigation software was developed to enable integrating 
these images. 
 
Results: Images from the four pulse sequences could be 
acquired within 50 minutes. The scans were well tolerated. 
All three volunteers reported slight vertigo while being 
moved in and out of the scanner. No other side effects of the 
7T field were reported. Increased geometrical distortion was 
observed in the cortex in close proximity to air-filled cavities 
(fig 1). Regional loss of signal and contrast could be 
minimized by placing dielectric pads between the head and 
the coil. Regions of increased signal were identified in the 
occipital and temporal lobes caused by residual B1-
inhomogeneities. Flow-artefacts were observed near major 
intra-cranial vessels. Image transfer and processing did not 
degrade image quality. Overall system-related geometrical 
distortion was ≤2 mm. Detailed results of the geometric 
distortion analysis are reported in the phantom study by 
Peerlings et al. 
 
 
Conclusion: Integration of high quality and geometrically 
reliable 7T MR images into neurosurgical navigation and RTP 
software is technically feasible. Quantification of object-
related geometrical distortion needs further analysis before 
clinical implementation. 
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Purpose or Objective: Treatment planning in radiation 
therapy based on MRI requires the generation of pseudo CTs 
for correct attenuation and dose calculation. We present a 
new algorithm for pseudo-CT generation which is based on 
localised correlations of intensity values extracted from T1-
weighted and T2-weighted MRIs to CT HU values, which 
doesn’t require UTE MRI sequences. 
 
Material and Methods: The images of 15 patients, treated for 
brain tumors, were used to implement and test the 
algorithm. Each image sets includes a T1-weighted MRI, a T2-
weighted MRI (each acquired with 3D-MPRAGE protocol with 
i.v. contrast agent) and a CT. The latter two were 
coregistered for each patient to match the T1-weighted MRI. 
Both of the MRIs in each set were segmented into 6 different 
tissue classes (white matter, gray matter, cerebrospinal 
fluid, bone, skin/soft tissue and air) based on an SPM8 
segmentation algorithm 
(http://www.fil.ion.ucl.ac.uk/spm/software/spm8/). 
In order to generate a pseudo-CT for one individual, we used 
the image sets of the remaining 14 patients to generate the 
voxel-wise T1, T2 to CT correlations for each of the tissue 
classes. These were then used as two dimensional lookup 
tables to translate the T1 and T2 values of the individual to 
pseudo-HU values. After the application of post-processing 
steps including smoothing, we compared the generated 
pseudo-CT to the acquired CT, by calculating the bias and 
the mean absolute error of the difference. 
We repeated this procedure for all 15 patients. 
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Results: The generated pseudo-CTs for the fifteen patients 
show low mean absolute error (138 ± 17 HU) and bias (-8 ± 29 
HU) in comparison to the acquired CT. These values are in 
the same range as a suggested algorithm by Sue et. al, which 
makes use of UTE MRI acquisitions (Med Phys. 2015 
Aug;42(8):4974-86.). 
 
Conclusion: Many suggested pseudo-CT generation methods 
employ a complicated ultra-short echo time (UTE) MRI for 
better bone segmentation. 
With our new approach, we show that pseudo-CTs of 
reasonable quality can be generated without the use of UTE 
MRI acquisitions. Currently, we are still improving our 
algorithm and at a pretty early stage of the overall 
development, thus further significant improvement can be 
expected. 
Furthermore, we plan to expand our algorithm to the 
application in pediatric oncology with the aim to reduce 
necessity of CT acquisitions (ionizing radiation exposure) for 
growing patients. 
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Purpose or Objective: Proton range in patients is 
determined from the stopping power ratio (SPR) of tissues 
relative to water along the beam path. SPR map can be 
derived from dual-energy computed tomography (DECT) and 
the Bethe-Bloch equation. In this study, we propose and 
compare the accuracy and the precision of several 
procedures to estimate the SPR from DECT. 
 
Material and Methods: Image-based method of [1] and 
projection-based basis material decomposition (BMD) method 
of [2] were investigated. 2 variants for BMD were considered: 
water/compact bone basis (W/CB) and 
photoelectric/Compton basis (Ph/Co) with exponent 
optimization for the given DE spectra. BMD assumes that 
linear attenuation coefficient at any energy can be obtained 
by a linear and energy-independent combination of these 
basis functions. Electron density ρe and effective atomic 
number Zeff are common DECT outputs. For each 
decomposition method, 4 empirical relationships to convert 
DE outputs to SPR were evaluated which were all calibrated 
with materials used by [3] for the stoichiometric calibration. 
The first approach [4] was a calibrated relation between the 
logarithm of the mean excitation energy of tissues Im and 
Zeff (Zeff,ln Im). The second approach consisted in 
reconstructing the electronic cross section at 100 keV σe,100 
from the BMD results. To avoid intermediate variable Zeff, a 
novel calibrated relation between σe,100 and Im values 
(σe,100, Im) was proposed. The third method involved a 
calibration curve between (σe,100, SPR/ρe). The last 
approach consisted in the direct conversion of ρe into SPR 
through the (ρe,SPR/ρe) relation proposed by [5]. Only the 
last method can be considered independent of the energy 
spectra.  
Virtual DECT acquisitions of the ImagingRing (medPhoton, 
Salzburg) of the phantom Gammex 467 were carried out by 
means of deterministic Monte Carlo simulations in Gate with 
realistic detector response model. Scatter-free fan-beam 
acquisitions with 720 projections were considered. Realistic 
Poisson noise corresponding to a 20mGy central dose was 
added to the projections. 
 
Results: Relative errors of SPRs of phantom inserts estimated 
using 4 empirical relationships for each decomposition 
method are shown in Table1 as μ ± σ. A penalty was imposed 
to pixel values with Im, Zeff and σe values outside human 
range. Lung tissue inserts show maximum error. (σe,100, 
SPR/ρe) approach is the least appropriate in terms of 
precision. (σe,100, Im) and (Zeff,ln Im) behave in the same 
manner. Results show that the method proposed by [5] 
provides better accuracy and precision. 
 
 
 
Conclusion: Comparison of different calibration methods to 
convert DE data into SPR was carried out. A novel 
relationship between σe and Im was proposed and behaves 
similarly to (Zeff,ln Im) curve. Energy independent poly-line 
(ρe,SPR/ρe) curves present better accuracy and precision.  
DECT is a promising technique to determine the SPR of 
human tissues. Optimization of the acquisition parameters 
and the algorithm to extract the required patient information 
is mandatory. 
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